Literature DB >> 36279013

Molecular imaging of the brain-heart axis provides insights into cardiac dysfunction after cerebral ischemia.

Nele Hermanns1, Viola Wroblewski1, Pablo Bascuñana1, Bettina Wolf1, Andras Polyak1, Tobias L Ross1, Frank M Bengel1, James T Thackeray2.   

Abstract

Ischemic stroke imparts elevated risk of heart failure though the underlying mechanisms remain poorly described. We aimed to characterize the influence of cerebral ischemic injury on cardiac function using multimodality molecular imaging to investigate brain and cardiac morphology and tissue inflammation in two mouse models of variable stroke severity. Transient middle cerebral artery occlusion (MCAo) generated extensive stroke damage (56.31 ± 40.39 mm3). Positron emission tomography imaging of inflammation targeting the mitochondrial translocator protein (TSPO) revealed localized neuroinflammation at 7 days after stroke compared to sham (3.8 ± 0.8 vs 2.6 ± 0.7 %ID/g max, p < 0.001). By contrast, parenchyma topical application of vasoconstrictor endothelin-1 did not generate significant stroke damage or neuroinflammatory cell activity. MCAo evoked a modest reduction in left ventricle ejection fraction at both 1 weeks and 3 weeks after stroke (LVEF at 3 weeks: 54.3 ± 5.7 vs 66.1 ± 3.5%, p < 0.001). This contractile impairment was paralleled by elevated cardiac TSPO PET signal compared to sham (8.6 ± 2.4 vs 5.8 ± 0.7%ID/g, p = 0.022), but was independent of leukocyte infiltration defined by flow cytometry. Stroke size correlated with severity of cardiac dysfunction (r = 0.590, p = 0.008). Statistical parametric mapping identified a direct association between neuroinflammation at 7 days in a cluster of voxels including the insular cortex and reduced ejection fraction (ρ = - 0.396, p = 0.027). Suppression of microglia led to lower TSPO signal at 7 days which correlated with spared late cardiac function after MCAo (r = - 0.759, p = 0.029). Regional neuroinflammation early after cerebral ischemia influences subsequent cardiac dysfunction. Total body TSPO PET enables monitoring of neuroinflammation, providing insights into brain-heart inter-organ communication and may guide therapeutic intervention to spare cardiac function post-stroke.
© 2022. The Author(s).

Entities:  

Keywords:  Heart failure; Magnetic resonance imaging; Positron emission tomography; Stroke; Translocator protein

Year:  2022        PMID: 36279013     DOI: 10.1007/s00395-022-00961-4

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   12.416


  46 in total

1.  Ischemic stroke activates hematopoietic bone marrow stem cells.

Authors:  Gabriel Courties; Fanny Herisson; Hendrik B Sager; Timo Heidt; Yuxiang Ye; Ying Wei; Yuan Sun; Nicolas Severe; Partha Dutta; Jennifer Scharff; David T Scadden; Ralph Weissleder; Filip K Swirski; Michael A Moskowitz; Matthias Nahrendorf
Journal:  Circ Res       Date:  2014-10-31       Impact factor: 17.367

2.  Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association.

Authors:  Robert J Adams; Marc I Chimowitz; Joseph S Alpert; Issam A Awad; Manuel D Cerqueria; Pierre Fayad; Kathryn A Taubert
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

3.  11C-Methionine PET Identifies Astroglia Involvement in Heart-Brain Inflammation Networking After Acute Myocardial Infarction.

Authors:  Pablo Bascuñana; Annika Hess; Tobias Borchert; Yong Wang; Kai C Wollert; Frank M Bengel; James T Thackeray
Journal:  J Nucl Med       Date:  2019-12-05       Impact factor: 10.057

4.  The spleen contributes to stroke-induced neurodegeneration.

Authors:  Craig T Ajmo; Dionne O L Vernon; Lisa Collier; Aaron A Hall; Svitlana Garbuzova-Davis; Alison Willing; Keith R Pennypacker
Journal:  J Neurosci Res       Date:  2008-08-01       Impact factor: 4.164

5.  The association of stroke and coronary heart disease: a population study.

Authors:  D D Dexter; J P Whisnant; D C Connolly; W M O'Fallon
Journal:  Mayo Clin Proc       Date:  1987-12       Impact factor: 7.616

6.  Neuroanatomic correlates of stroke-related myocardial injury.

Authors:  H Ay; W J Koroshetz; T Benner; M G Vangel; C Melinosky; E M Arsava; C Ayata; M Zhu; L H Schwamm; A G Sorensen
Journal:  Neurology       Date:  2006-03-08       Impact factor: 9.910

7.  Angiotensin-converting enzyme inhibitor treatment early after myocardial infarction attenuates acute cardiac and neuroinflammation without effect on chronic neuroinflammation.

Authors:  Tobias Borchert; Annika Hess; Mario Lukačević; Tobias L Ross; Frank M Bengel; James T Thackeray
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03-03       Impact factor: 9.236

8.  Dissecting the target leukocyte subpopulations of clinically relevant inflammation radiopharmaceuticals.

Authors:  Tobias Borchert; Laura Beitar; Laura B N Langer; Andras Polyak; Hans-Jürgen Wester; Tobias L Ross; Denise Hilfiker-Kleiner; Frank M Bengel; James T Thackeray
Journal:  J Nucl Cardiol       Date:  2019-10-28       Impact factor: 5.952

Review 9.  Brain-Heart Interaction: Cardiac Complications After Stroke.

Authors:  Zhili Chen; Poornima Venkat; Don Seyfried; Michael Chopp; Tao Yan; Jieli Chen
Journal:  Circ Res       Date:  2017-08-04       Impact factor: 17.367

10.  A Longitudinal PET/MRI Study of Colony-Stimulating Factor 1 Receptor-Mediated Microglia Depletion in Experimental Stroke.

Authors:  Cristina Barca; Amanda J Kiliaan; Claudia Foray; Lydia Wachsmuth; Sven Hermann; Cornelius Faber; Michael Schäfers; Maximilian Wiesmann; Andreas H Jacobs; Bastian Zinnhardt
Journal:  J Nucl Med       Date:  2021-06-24       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.